YXshen, CDXu, XHGao, DC Lin,GLLiu, . COMPARIS0N 0F MULTIPLE DOSAGE BI0AVAILABILITY BETWEEN PHENYLPROPANOLAMINE CONTROLLED RELEASE SUSPENSI0N AND CONVENTI0NAL TABLET IN HEALTHY VOLUNTEERSJ. Acta Pharmaceutica Sinica, 1995, 30(2): 157-160.
Citation: YXshen, CDXu, XHGao, DC Lin,GLLiu, . COMPARIS0N 0F MULTIPLE DOSAGE BI0AVAILABILITY BETWEEN PHENYLPROPANOLAMINE CONTROLLED RELEASE SUSPENSI0N AND CONVENTI0NAL TABLET IN HEALTHY VOLUNTEERSJ. Acta Pharmaceutica Sinica, 1995, 30(2): 157-160.

COMPARIS0N 0F MULTIPLE DOSAGE BI0AVAILABILITY BETWEEN PHENYLPROPANOLAMINE CONTROLLED RELEASE SUSPENSI0N AND CONVENTI0NAL TABLET IN HEALTHY VOLUNTEERS

  • Compared studies between the pharmacokinetics of phenylpropanolamine(PPA)controlled release suspension ( CRS ) and that of PPA conventional tablet in l0 healthy volunteers showed that the maximal plasma concentration(Cmax), the minimal plasma concentration(Cmin)and the fluctuation index (FI) values were 169. 06±7. 76 ng· ml-1, 82. 80±4; 29 ng· ml-1and 0. 20 ±0. 04 respectively for PPA CRS, 180. 05±8. 91 ng· ml-1, 76. 18±5. 97 ng·ml-1and 0.81±0.07 respectively for the conventional tablet. The Cnaxand FI of PPA CRS were significantly lower compared with those of the conventional tablet(P<0. 01 ) during steady state, The Cmin of PPA CRS was higher than that of the conventional tablet(P<0. 05)。
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return